Scientists test new drug combo to fight deadly brain Tumor's return
NCT ID NCT04391595
Summary
This study tested if two oral drugs, LY3214996 and abemaciclib, could reach brain tumors in people with recurrent glioblastoma. Up to 50 adults scheduled for surgery took the drugs before their operation so researchers could measure drug levels in the tumor tissue. The main goals were to see if the drugs penetrated the brain and if they helped control the cancer's growth after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chandler Regional Medical Center
Chandler, Arizona, 85224, United States
-
HonorHealth Scottsdale Osborn Medical Center
Scottsdale, Arizona, 85251, United States
-
St. Joseph's Hospital and Medical Center
Phoenix, Arizona, 85013, United States
Conditions
Explore the condition pages connected to this study.